CVE-2022-20863

Cisco Webex Meetings App Character Interface Manipulation Vulnerability

Description

A vulnerability in the messaging interface of Cisco Webex App, formerly Webex Teams, could allow an unauthenticated, remote attacker to manipulate links or other content within the messaging interface. This vulnerability exists because the affected software does not properly handle character rendering. An attacker could exploit this vulnerability by sending messages within the application interface. A successful exploit could allow the attacker to modify the display of links or other content within the interface, potentially allowing the attacker to conduct phishing or spoofing attacks.

Category

4.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.16%
Vendor Advisory cisco.com
Affected: Cisco Cisco Webex Meetings Desktop App
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-20863?
CVE-2022-20863 has been scored as a medium severity vulnerability.
How to fix CVE-2022-20863?
To fix CVE-2022-20863, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-20863 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-20863 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-20863?
CVE-2022-20863 affects Cisco Cisco Webex Meetings Desktop App.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.